Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. - Mackensen,A.; Herbst,B.; Chen,J.L.; Kohler,G.; Noppen,C.; Herr,W.; Spagnoli,G.C.; Cerundolo,V.; Lindemann,A. (Int J Cancer, 2000)